Wird geladen...

Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting β(2) agonists

BACKGROUND—In vitro the long acting β(2) agonist salmeterol can, in contrast to formoterol, behave as a partial agonist and become a partial antagonist to other β(2) agonists. To study this in vivo, the bronchodilating effect of salbutamol was measured during methacholine induced moderate to severe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: van der Woude, H J, Winter, T, Aalbers, R
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2001
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1746085/
https://ncbi.nlm.nih.gov/pubmed/11413351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thorax.56.7.529
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!